STAT5B and hematologic disorder: The apparent discrepancy between STAT5B’s predominantly protective associations in our analysis and prior reports of oncogenic STAT5B mutations (e.g., STAT5BN642H) in hematologic malignancies can be reconciled by considering activation state and mutational context.